Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.

Employees

809

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
14/09/26	$0.2453	-1.96%	321,584
11/09/26	$0.2502	+2.96%	698,394
10/09/26	$0.2430	-2.84%	622,761
09/09/26	$0.2501	-4.54%	359,580

Delayed Quote Nasdaq

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.2453USD

Average target price

0.3500USD

Spread / Average Target

+42.68%

Consensus

EPS Estimates

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nasdaq 23:00:00 14/09/2026 +03			5-day change	1st Jan Change
0.2453 ^USD	-1.96%		-8.06%	-70.25%

09-11	Accuray Incorporated and Raysearch Laboratories AB Enter into Collaboration Integrating Raystation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities	CI
09-11	Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy	MT

Market Cap	29.3M 25.39M 23.96M 21.73M 40.77M 2.81B 41.07M 286M 110M 1.42B 110M 108M 4.53B	P/E 2027 *	-0.82x	P/E 2028 *	-
Enterprise Value	29.3M 25.39M 23.96M 21.73M 40.77M 2.81B 41.07M 286M 110M 1.42B 110M 108M 4.53B	EV / Sales 2027 *	0.07x	EV / Sales 2028 *	-
Free-Float	93.21%	Yield 2027 *	-	Yield 2028 *	-

Markets		Quality
Nasdaq	ARAY	Delayed
Tradegate	XEJ	Real-time
CBOE	ARAY	Real-time
Deutsche Boerse AG	XEJ	Delayed
Börse Stuttgart	XEJ	Delayed
Boerse Muenchen	XEJ	Real-time

09-11	Accuray Incorporated and Raysearch Laboratories AB Enter into Collaboration Integrating Raystation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities	CI
09-11	Accuray, RaySearch to Collaborate on Adaptive Radiation Therapy	MT
08-20	Accuray Incorporated, Q4 2026 Earnings Call, Aug 19, 2026
08-19	Accuray Fiscal Q4 Swings to Loss, Revenue Falls	MT
08-19	Accuray Incorporated Reports Earnings Results for the Fourth Quarter Ended June 30, 2026	CI
08-13	Accuray Incorporated Announces Executive Appointments	CI
07-30	Accuray Enters Agreements With TCW Asset Management to Boost Financial Position, Liquidity	MT
07-30	Accuray Incorporated Announces Board Changes, Effective July 29, 2026	CI
07-29	Accuray Incorporated announced that it expects to receive $15 million in funding	CI
07-11	Accuray Incorporated Recalls 48 Units Cyberknife Treatment Deliver System Equipped with the Xchange Robotic Collimator Changer	CI
05-29	Accuray Incorporated reports inducement award under Nasdaq Listing Rules	RE
05-15	Accuray Incorporated And University Of Wisconsin School Of Medicine And Public Health Enter Master Research Agreement	CI
05-12	Accuray Shares Fall After Jefferies Downgrade	MT

Accuray Incorporated Stock

Stocks

ARAY

US0043971052

Advanced Medical Equipment & Technology

Valuation: Accuray Incorporated

Chart: Accuray Incorporated

Latest news: Accuray Incorporated

Last Transcript: Accuray Incorporated

Analysts' recommendations: Accuray Incorporated

Press Releases: Accuray Incorporated

News in other languages: Accuray Incorporated

Quotes and Performance

Price Extremes

Managers and Directors: Accuray Incorporated

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Analysts' Consensus

Quarterly revenue - Rate of surprise

09-11	Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities	PR
09-11	Accuray and RaySearch agree to collaboration integrating RayStation software with Accuray platforms to accelerate Accuray’s online adaptive capabilities	AQ
08-19	Accuray: Fiscal Q4 Earnings Snapshot	AQ
08-19	Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results	PR
08-13	Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments	PR

1 day	-1.96%
1 week	-8.06%
Current month	-6.73%
1 month	-11.83%
3 months	-28.13%
6 months	-33.77%
Current year	-70.25%

1 week	0.24	0.27
1 month	0.24	0.34
Current year	0.22	0.93
1 year	0.22	2.1
3 years	0.22	3.1
5 years	0.22	5.93
10 years	0.22	6.39

Manager	Title	Age	Since
Stephen la Neve CEO	Chief Executive Officer	67	20/10/2025
Ali Pervaiz DFI	Director of Finance/CFO	46	09/05/2022
Seth Blacksburg CTO	Chief Tech/Sci/R&D Officer	-	14/09/2022

Director	Title	Age	Since
Joseph Whitters CHM	Chairman	68	01/01/2021
James Hindman BRD	Director/Board Member	65	06/09/2019
Mika Nishimura BRD	Director/Board Member	62	17/08/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
5/29/26 A	Paul Miele	Free	Executive/Senior Manager	650,000	0.5472%
5/19/26 A	TCW Asset Management Co. LLC	Others	Company	3,474,107	2.9248%
4/17/26 A	TCW Asset Management Co. LLC	Other	Company	15,467,952	13.0221%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ACCURAY INCORPORATED	-1.96%	-8.06%	-84.38%	-91.14%	29.88M
THERMO FISHER SCIENTIFIC, INC.	+0.62%	-0.03%	+27.98%	+19.00%	225B
DANAHER CORPORATION	+1.55%	-2.12%	+6.95%	-19.82%	141B
INTUITIVE SURGICAL, INC.	+2.38%	+3.07%	-15.95%	+24.43%	130B
BOSTON SCIENTIFIC CORPORATION	+4.82%	-5.75%	-56.14%	-14.87%	62.29B
SIEMENS HEALTHINEERS AG	+1.99%	+0.96%	-18.12%	-13.93%	49.39B
EDWARDS LIFESCIENCES CORPORATION	+1.36%	-4.87%	+10.25%	+15.54%	48.63B
AGILENT TECHNOLOGIES, INC.	-0.09%	-2.69%	+19.12%	+27.79%	41.42B
WATERS CORPORATION	+0.41%	+0.15%	+38.80%	+50.73%	40.12B
RESMED, INC.	+2.16%	-2.35%	-17.45%	+51.04%	31.23B
Average	+1.32%	-2.42%	-8.89%	+4.88%	76.97B
Weighted average by Cap.	+1.58%	-1.31%	+4.05%	+11.17%

	2027 *	2028 *
Net sales	413M 358M 338M 306M 575M 39.58B 579M 4.03B 1.55B 20.08B 1.55B 1.52B 63.84B	-
Net income	-37.9M -32.84M -30.99M -28.12M -52.74M -3.63B -53.12M -370M -143M -1.84B -142M -139M -5.86B	-
Net Debt	-	-